Budget woes may linger at FDA

The partial government shutdown is hurting patients and drug companies by preventing FDA from accepting most new drug applications, and the harm may not end when the budget stalemate is resolved.

While it isn’t clear how the impasse over President Donald Trump’s demands for funding of a border wall will play out, one resolution could involve Congress abandoning an FDA funding boost that the House, Senate and President Donald Trump have all agreed it should receive. ...